Increasing visibility with a proactive supply chain

Document

Learn how one of the world’s largest pharma organisations saves millions of dollars and thousands of tonnes of CO2 with a clean, simple, and efficient supply chain.

3 August 2020

What is on this page?

Click to jump to a specific section below.

Introduction

Our whole story starts here

Mission and vision

Logipharma report

The logistics industry now has more data on shipments than ever before. With this mountain of new data comes the responsibility for pharmaceutical companies to figure out how best to implement a proactive model so that they can act on data.

In Q4 of 2018 WBR Insights, Logipharma surveyed 100 Heads of Operations from pharma companies across Europe to find out more about the challenges they’re facing and the innovative solutions being brought to the table.

CEO Niclas Ohlsson, share TSS's view on the superiority of a proactive supply chain and the importance of placing new technology in the right context for solving the business problems of tomorrow.

Highlights:

Recommendations on Implementing a Real-Time Monitoring Solution
A Glimpse into the Future of Pharma Logistics
The Evolving Digital Landscape
Increasing Visibility
Utilizing Real-Time Data

‍

Complete the form below to download a copy of the report.

‍

You may also be interested in

Three approaches for automating clinical supply chains

Our North America VP Evan Hahn, recently presented a webinar where he outlined three different approaches for automating clinical supply chains.

Reducing excursion evaluation time from days to seconds

The question of how to speed up clinical trials is complicated, especially considering that many trial stages simply cannot be rushed in the interest of trial subjects and the general public. However, process improvements can go a long way.

We’re attending LogiPharma 2022

We’re pleased to announce that we’re attending LogiPharma 2022, the world’s leading Pharma Supply event, from April 05th to April 07th, in Nice, France.

You may also be interested in

What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?

The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.

Extending TempMonitor BLE to Ultra-Low Temperatures

Introducing the new TSS Dry Ice Probes, enginereed for accurate and GxP-compliant temperature monitoring down to –90°C. Available in two lengths for flexible setup — built to safeguard product integrity in every environment.